The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ETCTN 10563: A phase I study of peposertib and liposomal doxorubicin for advanced or metastatic leiomyosarcoma and other sarcomas.
 
Candace Haddox
Employment - Dana-Farber Cancer Institute
Honoraria - Horizon CME; i3 Health
Consulting or Advisory Role - AADi; deciphera; SpringWorks Therapeutics
Research Funding - AADi (Inst); ASCO; Cogent Biosciences (Inst); EMD Serono/Merck (Inst); HiFiBiO Therapeutics (Inst); Roche/Genentech (Inst); Tango Therapeutics (Inst); Tubulis GmbH (Inst)
 
Karla Ballman
Consulting or Advisory Role - Agenus
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Mylan; Sanofi
 
Elise Nassif Haddad
Honoraria - Elsevier; Sonata Therapeutics
Consulting or Advisory Role - SpringWorks Therapeutics
 
Scott Schuetze
Consulting or Advisory Role - Deciphera
Research Funding - Adaptimmune (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Rain Therapeutics (Inst); Shanghai Pharma (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Deciphera
 
Melissa Burgess
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie
Research Funding - Merck
 
Alice Chen
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)
 
Ludimila Cavalcante
Employment - Actuate Therapeutics
Stock and Other Ownership Interests - Actuate Therapeutics
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; CDR-Life; Janssen; Pliant
 
Emily Jonczak
No Relationships to Disclose
 
Brian Van Tine
Leadership - Polaris
Honoraria - Beijing Biostar Pharmaceuticals Co., Ltd.; Oncology Education; Total Health Conference
Consulting or Advisory Role - Aadi; Acuta Capital Partners, LLC; Adaptimmune; Advenchen Laboratories; Boxer Capital LLC; Crisper Therapeutics; Daiihi Sankyo; Deciphera; Galapagos NV; Hinge Bio; Kronos Bio, Inc.; Putnam Associates; Salarius Pharmaceuticals, INc.; Syneos Health
Research Funding - Polaris
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; Kronos Bio, Inc
 
Steven Gore
No Relationships to Disclose
 
Jonathan Fletcher
Consulting or Advisory Role - ARIAD
Research Funding - Von Pfeffel Pharma
Patents, Royalties, Other Intellectual Property - Novartis - Imatinib
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories (I); Pfizer (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; deciphera; Kayothera; UpToDate
Research Funding - Acrivon Therapeutics (Inst); BioAtla; Blueprint Medicines (Inst); Daiichi Sankyo RD Novare (Inst); Deciphera (Inst); Eisai (Inst); IDRx (Inst); Merck (Inst); NewBay Pharma (Inst); SpringWorks Therapeutics (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
Other Relationship - WCG